John W Childs bought $996k of BHVN
director at Biohaven Ltd.. 32,700 shares at an average of $30.47, traded Mar 4, 2025, filed Mar 5, 2025.
Score components
- +15RoleDirector
- +25Trade size$996k at market
- 0Relative to holdingsHoldings up 1.4%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001935979-25-000018, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 4, 2025 | POpen-market purchase Common Sharesindirect: By John W Childs 2013 Revocable Trust | +25,000 | $30.39 | $760k | 2,320,571 | Mar 5, 2025 |
| Mar 4, 2025 | POpen-market purchase Common Sharesindirect: By 2007 Charitable Remainder Trust | +3,400 | $30.73 | $104k | 24,452 | Mar 5, 2025 |
| Mar 4, 2025 | POpen-market purchase Common Sharesindirect: By 2013 Charitable Remainder Trust | +3,400 | $30.73 | $104k | 76,570 | Mar 5, 2025 |
| Mar 4, 2025 | POpen-market purchase Common Sharesindirect: By 1994 Charitable Remainder Trust | +900 | $30.73 | $28k | 25,291 | Mar 5, 2025 |
Related signals
Other insiders at Biohaven Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | BHVNbuy Biohaven Ltd. | John W Childs director | $1.0M 29,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.